Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes and endpoints of postoperative recurrence in Crohn's Disease: systematic review and consensus conference.
Hammoudi N, Sachar D, D'Haens G, Reinisch W, Kotze PG, Vermeire S, Schölmerich J, Kamm MA, Griffiths A, Panes J, Ghosh S, Siegel CA, Bemelman W, O'Morain C, Steinwurz F, Fleshner P, Mantzaris GJ, Sands B, Abreu MT, Dotan I, Turner D, Dignass A, Allez M; International Organization for the Study of Inflammatory Bowel Diseases (IOIBD).. Hammoudi N, et al. Among authors: panes j. J Crohns Colitis. 2023 Dec 19:jjad205. doi: 10.1093/ecco-jcc/jjad205. Online ahead of print. J Crohns Colitis. 2023. PMID: 38112601
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.
Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E; European Crohn's and Colitis Organisation (ECCO). Van Assche G, et al. Among authors: panes j. J Crohns Colitis. 2010 Feb;4(1):7-27. doi: 10.1016/j.crohns.2009.12.003. Epub 2010 Jan 15. J Crohns Colitis. 2010. PMID: 21122488 Free article. No abstract available.
Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort.
Gower-Rousseau C, Sarter H, Savoye G, Tavernier N, Fumery M, Sandborn WJ, Feagan BG, Duhamel A, Guillon-Dellac N, Colombel JF, Peyrin-Biroulet L; International Programme to Develop New Indexes for Crohn's Disease (IPNIC) group; International Programme to Develop New Indexes for Crohn's Disease (IPNIC) group. Gower-Rousseau C, et al. Gut. 2017 Apr;66(4):588-596. doi: 10.1136/gutjnl-2015-310151. Epub 2015 Dec 8. Gut. 2017. PMID: 26646934
Achievement of clinical, endoscopic, and histologic outcomes in patients with ulcerative colitis treated with etrasimod, and association with fecal calprotectin and C-reactive protein: results from the Phase 2 OASIS trial.
Yarur AJ, Chiorean MV, Panés J, Jairath V, Zhang J, Rabbat CJ, Sandborn WJ, Vermeire S, Peyrin-Biroulet L. Yarur AJ, et al. Among authors: panes j. J Crohns Colitis. 2024 Jan 20:jjae007. doi: 10.1093/ecco-jcc/jjae007. Online ahead of print. J Crohns Colitis. 2024. PMID: 38245818
Cyclophosphamide-free mobilisation increases safety while preserving the efficacy of autologous haematopoietic stem cell transplantation in refractory Crohn's disease patients.
Giordano A, Rovira M, Veny M, Barastegui R, Marín P, Martínez C, Fernández-Avilés F, Suárez-Lledó M, Domènech A, Serrahima A, Lozano M, Cid J, Ordás I, Fernández-Clotet A, Caballol B, Gallego M, Vara A, Masamunt MC, Giner À, Teubel I, Esteller M, Corraliza AM, Panés J, Salas A, Ricart E. Giordano A, et al. Among authors: panes j. J Crohns Colitis. 2024 May 17:jjae076. doi: 10.1093/ecco-jcc/jjae076. Online ahead of print. J Crohns Colitis. 2024. PMID: 38757210
Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's disease.
Fernández-Clotet A, Ordás I, Masamunt MC, Caballol B, Rodríguez S, Gallego M, Barastegui R, Saavedra AC, Panés J, Ricart E, Rimola J. Fernández-Clotet A, et al. Among authors: panes j. Aliment Pharmacol Ther. 2024 Jun;59(11):1435-1445. doi: 10.1111/apt.17968. Epub 2024 Apr 23. Aliment Pharmacol Ther. 2024. PMID: 38650481
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.
Peyrin-Biroulet L, Dubinsky MC, Sands BE, Panés J, Schreiber S, Reinisch W, Feagan BG, Danese S, Yarur AJ, D'Haens GR, Goetsch M, Wosik K, Keating M, Lazin K, Wu J, Modesto I, McDonnell A, Bartolome L, Vermeire S. Peyrin-Biroulet L, et al. Among authors: panes j. J Crohns Colitis. 2024 Apr 13:jjae038. doi: 10.1093/ecco-jcc/jjae038. Online ahead of print. J Crohns Colitis. 2024. PMID: 38613425
476 results